Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1966 Mar;19(2):185–189. doi: 10.1136/jcp.19.2.185

Antiplasmin activity of electrophoretically separated human serum fractions

R D Mann 1, Susan Cotton 1, D Jackson 1
PMCID: PMC473229  PMID: 4160096

Abstract

The antiplasmin which migrates electrophoretically with the alpha2 globulins preponderates in effect over that of the alpha1 migrating antiplasmin. This preponderance persists at physiological pH value in vitro and the significance of this finding is discussed.

No evidence has been obtained of the existence of anti-urokinase activity in antiplasmin-free serum fractions.

Full text

PDF
185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMBRUS C. M., MARKUS G. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme. Am J Physiol. 1960 Sep;199:491–494. doi: 10.1152/ajplegacy.1960.199.3.491. [DOI] [PubMed] [Google Scholar]
  2. FEARNLEY G. R. Fibrinolysis by adsorption. Nature. 1953 Sep 19;172(4377):544–545. doi: 10.1038/172544b0. [DOI] [PubMed] [Google Scholar]
  3. MAKI M., NAGASAWA K. Pathophysiology of plasmin system. II. Fibrinolysis and plasmin (activator)--inhibitor ratio. Tohoku J Exp Med. 1963 Jan 25;78:363–369. doi: 10.1620/tjem.78.363. [DOI] [PubMed] [Google Scholar]
  4. NANNINGA L. B., GUEST M. M. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR. Arch Biochem Biophys. 1964 Dec;108:542–551. doi: 10.1016/0003-9861(64)90440-0. [DOI] [PubMed] [Google Scholar]
  5. NILSSON I. M., KROOK H., STERNBY N. H., SODERBERG E., SODERSTROM N. Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. Acta Med Scand. 1961 Mar;169:323–337. doi: 10.1111/j.0954-6820.1961.tb07838.x. [DOI] [PubMed] [Google Scholar]
  6. NORMAN P. S., HILL B. M. Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma. J Exp Med. 1958 Nov 1;108(5):639–649. doi: 10.1084/jem.108.5.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. NORMAN P. S. Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma. J Exp Med. 1958 Jul 1;108(1):53–68. doi: 10.1084/jem.108.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. RIDING I. M., ELLIS D. ANTIPLASMIN ACTIVITY OF BETA-LIPOPROTEIN. J Atheroscler Res. 1964 Mar-Apr;4:189–192. doi: 10.1016/s0368-1319(64)80039-9. [DOI] [PubMed] [Google Scholar]
  9. RYBAK M. A study of the plasmin-inhibitor reaction. Physiol Bohemoslov. 1962;11:470–477. [PubMed] [Google Scholar]
  10. RYBAK M., REJNEK J. The antiplasmin effect of plasma fractions. Clin Chim Acta. 1959 May;4(3):364–368. doi: 10.1016/0009-8981(59)90103-2. [DOI] [PubMed] [Google Scholar]
  11. SHERRY S., FLETCHER A. P., ALKJAERSIG N. Fibrinolysis and fibrinolytic activity in man. Physiol Rev. 1959 Apr;39(2):343–382. doi: 10.1152/physrev.1959.39.2.343. [DOI] [PubMed] [Google Scholar]
  12. TAYLOR F. B., Jr, ALLEN L. W., BICKFORD A. F., Jr FRACTIONATION AND CHARACTERIZATION OF AN INHIBITOR OF PLASMIN FOUND IN NORMAL PLASMA. Arch Biochem Biophys. 1964 Feb;104:277–281. doi: 10.1016/s0003-9861(64)80014-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES